Neurelis has a proprietary technology portfolio that includes Intravail®, ProTek®, and Hydrogel™ for drug delivery enhancement. These three non-invasive drug delivery and stabilization technologies are applicable to a wide range of molecules including therapeutic proteins, peptides, and non-peptide large and small molecules. I was in charge of creating the technologies page that will impact the product pipeline with the help of investments.

See the full site here: https://www.neurelis.com/our-technologies